Reyes Ferreiro

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design.

A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design.

Journal: Future oncology (London, England)
Published: January 06, 2026

Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study.

Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study.

Journal: ESMO open
Published: March 22, 2025

Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer.

Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer.

Journal: Future science OA
Published: November 22, 2024

Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.

Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 31, 2022

Correction: Earl et al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers 2021, 13, 1612.

Correction: Earl et al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers 2021, 13, 1612.

Journal: Cancers
Published: June 09, 2021

Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival.

Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival.

Journal: Cancers
Published: March 12, 2021

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.

Journal: Cancers
Published: February 18, 2021

Onset of ulcerative colitis and complete response during the treatment of a metastatic colon cancer: case report and literature review.

Onset of ulcerative colitis and complete response during the treatment of a metastatic colon cancer: case report and literature review.

Journal: Anti-cancer drugs
Published: February 15, 2021

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis.

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis.

Journal: Drugs & aging
Published: January 07, 2021

Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma.

Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma.

Journal: Cancers
Published: October 28, 2020

Watch and wait approach in rectal cancer: Current controversies and future directions.

Watch and wait approach in rectal cancer: Current controversies and future directions.

Journal: World journal of gastroenterology
Published: March 30, 2020

A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.

A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.

Journal: EBioMedicine
Published: September 30, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026